More good news came yesterday for Hospira‘s (NYSE:HSP) once-beleaguered infusion pump business when the FDA granted 510(k) clearance for its latest Plum 360 pump.
Lake Forest, Ill.-based Hospira said the Plum 360 is based on the Plum A+ platform’s air management and secondary delivery features. The device uses Hospira’s MedNet safety software and features an expanded drug library and can wirelessly update patients’ medical records.
"Hospira is excited to announce clearance of the Plum 360 infusion system in the United States – another important milestone in our continued path to streamline and modernize our device portfolio," Hospira Medical Devices president David Endicott said in prepared remarks. "Hospira will continue to develop and launch the most technologically advanced infusion pumps in the industry for our customers and patients."
Hospira said it expects to have the Plum 360 on the U.S. market "in the coming weeks."
Earlier this month, Hospira logged an important win after the FDA lifted an import ban on its infusion pumps made in Costa Rica, more than 2 years after the watchdog agency 1st barred them from the U.S. market.